4//SEC Filing
Cellular Biomedicine Group, Inc. 4
Accession 0001354488-15-004726
CIK 0001378624operating
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 7:50 PM ET
Size
15.1 KB
Accession
0001354488-15-004726
Insider Transaction Report
Form 4
Cao Wei (William)
DirectorPresident and COO
Transactions
- Sale
Common Stock
2015-10-20$18.89/sh−5,013$94,696→ 222,518 total - Exercise/Conversion
Non- Qualified Stock Option
2015-10-21+14,987→ 70,000 totalExercise: $5.40Exp: 2023-09-29→ Common Stock (14,987 underlying) - Exercise/Conversion
Common Stock
2015-10-20$5.40/sh+5,013$27,070→ 227,531 total - Exercise/Conversion
Non- Qualified Stock Option
2015-10-20+5,013→ 84,987 totalExercise: $5.40Exp: 2023-09-29→ Common Stock (5,013 underlying) - Exercise/Conversion
Common Stock
2015-10-21$5.40/sh+14,987$80,930→ 237,505 total - Award
Non- Qualified Stock Option
2013-09-30+90,000→ 90,000 totalExercise: $5.40Exp: 2023-09-29→ Common Stock (90,000 underlying) - Sale
Common Stock
2015-10-21$19.83/sh−14,987$297,192→ 222,518 total
Footnotes (2)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- [F2]This option vests over a period of three-year years according to the following schedule: 1/36th per month following the vesting commencement date of 09/30/2013.
Documents
Issuer
Cellular Biomedicine Group, Inc.
CIK 0001378624
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001378624
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 7:50 PM ET
- Size
- 15.1 KB